For more than 10 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in 35 countries worldwide.
FHI Clinical has long-standing relationships, a local team and broad expertise in sub-Saharan Africa. We're ready to help you confidently expand your research across the region, finding the best-fit countries and populations for your target indication and study type.
In this video, FHI Clinical experts share their final thoughts following a fall 2021 trip to Liberia to visit the PREVAIL network of sites and staff.
Watch this video to hear FHI Clinical experts detail upcoming research projects the PREVAIL network is excited to embark on, including a Lassa fever program.
FHI Clinical experts discuss their observations on the effects of COVID-19 on the local healthcare system during their fall 2021 visit to the Liberian PREVAIL sites.
Hear from a team of FHI Clinical experts as they discuss the importance of having localized expertise on the ground to build research capacity and site sustainability.
Watch this video to learn about the action items put into place following a visit to each of the PREVAIL network sites in Liberia, such as implementing productivity metrics and clarifying roles and responsibilities.
Following a trip to the PREVAIL network of sites in Liberia, we asked FHI Clinical team members for their feedback on the types of training, knowledge and skills that are important for the site staff to encompass. Watch this video to learn what qualities the experts evaluated during their trip.
Upon their return from visiting Liberia and the PREVAIL network sites, we asked a team of FHI Clinical experts what they learned during their time in the country.
In the fall of 2021, a small team from FHI Clinical headed to Liberia to meet the FHI Clinical PREVAIL network team. Watch this video to learn more about the purpose and goals of their trip.